London Alternative Investment Market (AIM)-listed biotech startup, BiVictriX Technologies, has appointed Glyn Baker as its new CFO. Baker joins in a non-board role based in the UK.
Nice choice! This is premium CorporateTreasurer content.
Subscribers can sign in for full unlimited access.
New user? Sign up for a one-time 7-day unlimited free trial.
If you are a treasurer, CFO or senior professional at a corporate or SME, please register for free VIP access here.